Solven 5 mg filmom obložene tablete
| Name | Solven 5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-616213056 |
| Active Substance | solifenacinsukcinat |
| Composition | svaka filmom obložena tableta sadrži 5 mg solifenacinsukcinata, što odgovara 3,8 mg solifenacina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | McDermott Laboratories Limited, t/a Gerard Laboratories, Dublin 13, Irska Mylan Hungary Kft, Komárom, Mađarska Mylan Germany GmbH , Bad Homburg, Hesse, Njemačka |
| Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 01.02.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/254 |
| Registration Number | 381-12-01/154-22-12 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BD08 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
